Insider Selling: Atlassian (NASDAQ:TEAM) Director Sells 7,665 Shares of Stock

Atlassian Corporation PLC (NASDAQ:TEAMGet Free Report) Director Scott Farquhar sold 7,665 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $144.02, for a total transaction of $1,103,913.30. Following the completion of the sale, the director owned 199,290 shares of the company’s stock, valued at approximately $28,701,745.80. The trade was a 3.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Scott Farquhar also recently made the following trade(s):

  • On Wednesday, November 19th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $147.63, for a total transaction of $1,131,583.95.
  • On Monday, November 17th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $147.41, for a total value of $1,129,897.65.
  • On Thursday, November 13th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $153.77, for a total transaction of $1,178,647.05.
  • On Monday, November 10th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $158.00, for a total value of $1,211,070.00.
  • On Friday, November 7th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $155.58, for a total transaction of $1,192,520.70.
  • On Wednesday, November 5th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $162.66, for a total value of $1,246,788.90.
  • On Monday, November 3rd, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $172.79, for a total value of $1,324,435.35.
  • On Friday, October 31st, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $167.61, for a total transaction of $1,284,730.65.
  • On Wednesday, October 29th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $160.41, for a total transaction of $1,229,542.65.
  • On Monday, October 27th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $165.03, for a total transaction of $1,264,954.95.

Atlassian Stock Performance

NASDAQ TEAM traded up $0.17 on Monday, hitting $146.45. 3,597,884 shares of the company traded hands, compared to its average volume of 2,514,383. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 0.72. The business’s 50 day moving average price is $158.53 and its 200-day moving average price is $181.54. The company has a market capitalization of $38.53 billion, a price-to-earnings ratio of -206.26, a P/E/G ratio of 34.69 and a beta of 0.95. Atlassian Corporation PLC has a 52-week low of $139.70 and a 52-week high of $326.00.

Atlassian (NASDAQ:TEAMGet Free Report) last posted its quarterly earnings data on Thursday, October 30th. The technology company reported $1.04 EPS for the quarter, topping the consensus estimate of $0.83 by $0.21. The firm had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.40 billion. Atlassian had a negative return on equity of 7.11% and a negative net margin of 3.38%.The business’s revenue for the quarter was up 20.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.77 earnings per share. Atlassian has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Equities analysts expect that Atlassian Corporation PLC will post -0.34 earnings per share for the current year.

Institutional Trading of Atlassian

A number of institutional investors have recently bought and sold shares of TEAM. Capco Asset Management LLC purchased a new stake in Atlassian in the second quarter valued at $25,000. Physician Wealth Advisors Inc. boosted its holdings in Atlassian by 60.4% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock worth $26,000 after buying an additional 61 shares during the last quarter. Atlantic Union Bankshares Corp lifted its position in shares of Atlassian by 19,900.0% in the third quarter. Atlantic Union Bankshares Corp now owns 200 shares of the technology company’s stock valued at $32,000 after acquiring an additional 199 shares in the last quarter. Smithfield Trust Co boosted its stake in shares of Atlassian by 90.7% in the first quarter. Smithfield Trust Co now owns 164 shares of the technology company’s stock worth $34,000 after acquiring an additional 78 shares during the last quarter. Finally, Geneos Wealth Management Inc. grew its holdings in shares of Atlassian by 447.2% during the first quarter. Geneos Wealth Management Inc. now owns 197 shares of the technology company’s stock worth $42,000 after buying an additional 161 shares in the last quarter. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

TEAM has been the topic of several analyst reports. Barclays lowered their price target on shares of Atlassian from $244.00 to $215.00 and set an “overweight” rating on the stock in a report on Friday, August 8th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $260.00 price objective on shares of Atlassian in a research note on Friday, October 31st. Cowen reissued a “hold” rating on shares of Atlassian in a research note on Monday, October 27th. Mizuho boosted their price target on Atlassian from $235.00 to $245.00 and gave the stock an “outperform” rating in a report on Friday, October 31st. Finally, KeyCorp dropped their price target on Atlassian from $250.00 to $210.00 and set an “overweight” rating for the company in a research note on Thursday, October 23rd. One investment analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Atlassian presently has a consensus rating of “Moderate Buy” and a consensus target price of $240.00.

Check Out Our Latest Analysis on TEAM

About Atlassian

(Get Free Report)

Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams.

Recommended Stories

Insider Buying and Selling by Quarter for Atlassian (NASDAQ:TEAM)

Receive News & Ratings for Atlassian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlassian and related companies with MarketBeat.com's FREE daily email newsletter.